• Belkyra
己研

Belkyra

Description

BELKYRA® injection, containing the cytolytic agent deoxycholic acid (as the active ingredient), can improve double chin and moderate to severe submental fat accumulation.

BELKYRA® was officially approved by the US FDA on April 29, 2015, and has been widely and safely used worldwide to improve submental fat. In Taiwan, it was officially approved by the Ministry of Health and Welfare on April 28, 2017.

Pre-Treatment Precautions

• If the treatment area of your skin is experiencing an allergic reaction or inflammation, please wait until it has healed before receiving the injection.
• Patients with excessively loose skin and prominent neck lines may experience results that differ from their expectations.
• If you are currently taking ginseng, fish oil, ginkgo, aspirin, vitamin E, or other foods or medications that promote blood circulation, the chance of post-treatment bruising is slightly higher, but the injection can still be administered.

• Please inform your doctor beforehand if you have a history of or are currently experiencing difficulty swallowing or bleeding issues.

Post-Treatment Precautions

  • You can massage the treated area frequently within one week to accelerate swelling reduction and fat metabolism.
  • Post-treatment, swelling, bruising, pain, numbness, redness, and hard lumps in the treated area may occur and will gradually improve over time.
  • If bruising occurs, you can apply ice for the first two days after treatment, then use warm compresses to accelerate bruise dissipation.